Bullish option flow detected in Iovance Biotherapeutics with 5,408 calls trading, 1.3x expected, and implied vol increasing over 1 point to 76.34%. Sep-24 10.5 calls and Jan-25 10 calls are the most active options, with total volume in those strikes near 3,700 contracts. The Put/Call Ratio is 0.29. Earnings are expected on November 5th.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IOVA:
- Iovance Biotherapeutics call volume above normal and directionally bullish
- Iovance Biotherapeutics to Present at Upcoming Conferences
- Iovance Biotherapeutics put volume heavy and directionally bearish
- Iovance Biotherapeutics ‘pretty attractive long idea,’ says Martin Shkreli
- Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)